Researchers Recommend the Membrane Protein Flotillin as a Biomarker for Alzheimer’s Disease
|
By LabMedica International staff writers Posted on 12 Nov 2019 |
|
Image: Serum flotillin levels in patients with AD were lower than those in non-AD cases (Photo courtesy of Makoto Michikawa, Nagoya City University)
A team of Japanese researchers have suggested adding the protein flotillin to the arsenal of biomarkers that can be used to diagnose Alzheimer’s disease.
Flotillins are membrane proteins that form microdomains in the plasma membrane of all mammalian cell types studied to date. They span the evolutionary spectrum, with proteins related to flotillins present in bacteria, fungi, plants, and metazoans, which suggests that they perform important, and probably conserved, functions. Flotillins have been implicated in myriad processes that include endocytosis, signal transduction, and regulation of the cortical cytoskeleton, yet the molecular mechanisms that underlie flotillin function in these different cases are still poorly understood.
Investigators at Nagoya City University (Japan) had shown previously that flotillin release was reduced by amyloid beta (Abeta), a well known Alzheimer’s disease (AD) biomarker. Therefore, they designed the current study to determine whether flotillin levels would be reduced in the cerebral spinal fluid (CSF) and/or serum of patients with AD.
For this study, the investigators used western blotting to analyze flotillin levels in the CSF and serum of non-AD controls and of patients with AD and mild cognitive impairment (MCI). Flotillin levels in cerebroventricular fluid (CVF) and serum of AD, vascular dementia (VaD), and non-AD autopsy cases were also analyzed.
Results revealed that flotillin levels were significantly lower in the CSF and serum of AD patients compared with those of non-AD controls. Moreover, in patients with MCI due to AD, CSF and serum flotillin levels were significantly decreased compared with those of patients with MCI not due to AD. Flotillin levels remained unchanged in CVF and serum of autopsy cases diagnosed as VaD. Serum flotillin level was negatively associated with deposition of amyloid plaques in the brain.
The investigators postulated that these results, which were published in the October 29, 2019, online edition of the Journal of Alzheimer's Disease, demonstrated that serum flotillin level could serve as one of the blood markers for estimation of brain amyloid deposition and early diagnosis of AD.
Related Links:
Nagoya City University
Flotillins are membrane proteins that form microdomains in the plasma membrane of all mammalian cell types studied to date. They span the evolutionary spectrum, with proteins related to flotillins present in bacteria, fungi, plants, and metazoans, which suggests that they perform important, and probably conserved, functions. Flotillins have been implicated in myriad processes that include endocytosis, signal transduction, and regulation of the cortical cytoskeleton, yet the molecular mechanisms that underlie flotillin function in these different cases are still poorly understood.
Investigators at Nagoya City University (Japan) had shown previously that flotillin release was reduced by amyloid beta (Abeta), a well known Alzheimer’s disease (AD) biomarker. Therefore, they designed the current study to determine whether flotillin levels would be reduced in the cerebral spinal fluid (CSF) and/or serum of patients with AD.
For this study, the investigators used western blotting to analyze flotillin levels in the CSF and serum of non-AD controls and of patients with AD and mild cognitive impairment (MCI). Flotillin levels in cerebroventricular fluid (CVF) and serum of AD, vascular dementia (VaD), and non-AD autopsy cases were also analyzed.
Results revealed that flotillin levels were significantly lower in the CSF and serum of AD patients compared with those of non-AD controls. Moreover, in patients with MCI due to AD, CSF and serum flotillin levels were significantly decreased compared with those of patients with MCI not due to AD. Flotillin levels remained unchanged in CVF and serum of autopsy cases diagnosed as VaD. Serum flotillin level was negatively associated with deposition of amyloid plaques in the brain.
The investigators postulated that these results, which were published in the October 29, 2019, online edition of the Journal of Alzheimer's Disease, demonstrated that serum flotillin level could serve as one of the blood markers for estimation of brain amyloid deposition and early diagnosis of AD.
Related Links:
Nagoya City University
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Latest Molecular Diagnostics News
- Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear
- First-of-Its-Kind Blood Test Detects Over 50 Cancer Types
- Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk
- Single Cell RNA Sequencing Could Enable Non-Invasive Blood Disorder Diagnosis
- Blood Test Identifies HPV-Associated Head and Neck Cancers 10 Years Before Symptoms
- Giant DNA Elements Discovered in Mouth Could Impact Oral Health
- Simple Blood Test Spots Disease Through Metabolic Distortion
- Simple Blood Test Could Streamline Early Alzheimer's Detection
- Unique Microbial Fingerprint to Improve Diagnosis of Colorectal Cancer
- ELISA-Based Test Uses Gynecologic Fluids to Detect Endometrial Cancer
- Comprehensive Tumor Profiling Kit Decentralizes and Standardizes Oncology Testing
- Automated Syndromic Testing System Combines Unparalleled Throughput with Simple Workflow
- Simple Urine Test Assesses Risk of Kidney Cancer Recurrence at Early Stage
- Molecular Map Reveals Previously Hidden Connections Between Diseases
- Novel Urine-Based Test Detects Prostate Cancers
- MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence
Channels
Clinical Chemistry
view channel
Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
Ovarian cancer is considered one of the deadliest cancers, in part because it rarely shows clear symptoms in its early stages, and diagnosis is often complex. Current approaches make it difficult to accurately... Read more
Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more
Hematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more
Immunology
view channel
Novel Tool Uses Deep Learning for Precision Cancer Therapy
Nearly 50 new cancer therapies are approved each year, but selecting the right one for patients with highly individual tumor characteristics remains a major challenge. Physicians struggle to navigate the... Read more
Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients
Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more
Microbiology
view channel
Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Sepsis arises from infection and immune dysregulation, with neutrophils playing a central role in its progression. However, current clinical tools are unable to both isolate these cells and assess their... Read more
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma
Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Clinicopathologic Study Supports Exclusion of Cervical Serous Carcinoma from WHO Classification
High-grade serous carcinoma is a rare diagnosis in cervical biopsies and can be difficult to distinguish from other tumor types. Cervical serous carcinoma is no longer recognized as a primary cervical... Read more
Technology
view channel
Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine
The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Rapid Diagnostic Technology Utilizes Breath Samples to Detect Lower Respiratory Tract Infections
Respiratory tract infections (LRTIs) are leading causes of illness and death worldwide, particularly among vulnerable populations such as the elderly, young children, and those with compromised immune systems.... Read more
Industry
view channel
VedaBio Partners With Mammoth Biosciences to Expand CRISPR-Based Diagnostic Technologies
VedaBio (San Diego, CA, USA) has entered into a non-exclusive license agreement with Mammoth Biosciences (Brisbane, CA, USA) for the use of select CRISPR-based technologies in diagnostic applications.... Read more
